Darin Lippoldt, CLO of Neurocrine Biosciences NBIX, has filed 0 purchases and 23 sales on the open market. Over the past 12 months that comes to a net sale of $2.4M. The latest trade was on 06/29.

Darin Lippoldt

Chief Legal Officer

Company

Neurocrine Biosciences NBIX

First filing

23/02/02

Trades

74 trades

Buys / sales

0 / 23

12-month net buying

−$2.4M

Last trade

06/29

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Neurocrine BiosciencesNBIX	Open-market sale10b5-1 plan	06/26–06/29	06/30	10,000 sh3 trades	$170.15avg.	$1,701,526.2	−15.4%
Neurocrine BiosciencesNBIX	Open-market sale10b5-1 plan	25/12/08	25/12/10	4,376 sh	$159.65	$698,628.4	−9.2%
Neurocrine BiosciencesNBIX	Open-market sale10b5-1 plan	25/02/13	25/02/14	2,184 sh2 trades	$116.76avg.	$254,992.98	−4.8%
Neurocrine BiosciencesNBIX	Open-market sale10b5-1 plan	25/02/10	25/02/12	911 sh	$118.25	$107,725.75	−2.1%
Neurocrine BiosciencesNBIX	Open-market sale10b5-1 plan	25/01/31	25/02/04	1,250 sh	$152.91	$191,137.5	−3.0%
Neurocrine BiosciencesNBIX	Open-market sale10b5-1 plan	24/08/01	24/08/05	2,996 sh	$154.01	$461,413.96	−7.0%
Neurocrine BiosciencesNBIX	Open-market sale10b5-1 plan	24/07/16	24/07/18	7,004 sh	$150.00	$1,050,600	−15.0%
Neurocrine BiosciencesNBIX	Open-market sale10b5-1 plan	24/02/13	24/02/15	1,098 sh	$132.99	$146,023.02	−2.7%
Neurocrine BiosciencesNBIX	Open-market sale10b5-1 plan	24/02/06–24/02/08	24/02/08	1,952 sh2 trades	$138.47avg.	$270,291.61	−4.8%
Neurocrine BiosciencesNBIX	Open-market sale10b5-1 plan	24/01/31	24/02/02	1,250 sh	$140.65	$175,812.5	−3.3%
Neurocrine BiosciencesNBIX	Open-market sale10b5-1 plan	24/01/22	24/01/24	10,000 sh	$139.86	$1,398,600	−21.8%
Neurocrine BiosciencesNBIX	Open-market sale10b5-1 plan	23/12/06	23/12/08	20,830 sh	$119.86	$2,496,683.8	−36.7%
Neurocrine BiosciencesNBIX	Open-market sale10b5-1 plan	23/11/27	23/11/29	10,919 sh	$112.27	$1,225,876.13	−23.3%
Neurocrine BiosciencesNBIX	Open-market sale10b5-1 plan	23/08/21	23/08/23	2,132 sh	$107.39	$228,955.48	−4.3%
Neurocrine BiosciencesNBIX	Open-market sale	23/02/06–23/02/08	23/02/08	16,275 sh4 trades	$102.71avg.	$1,671,642.38	−26.6%
Neurocrine BiosciencesNBIX	Open-market sale	23/01/31	23/02/02	1,250 sh	$109.97	$137,462.5	−4.0%